newsfilter
← Latest News
Business Wire·

Regencell Bioscience Holdings Limited Announces Partial Exercise of Underwriter's Over-Allotment Option

Regencell Bioscience Holdings Limited (NASDAQ:RGC) ("Regencell" or the "Company"), an early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine ("TCM") for the treatment of neurocognitive